Rhinocladiella mackenziei cerebral phaeohyphomycosis with a definitive outcome

BMJ Case Rep. 2023 May 23;16(5):e250787. doi: 10.1136/bcr-2022-250787.

Abstract

A right-handed man in his early 60s with hypertension controlled by a single prescription medication presented with left-sided heaviness and intermittent right occipital headache. Initial diagnostic workup was unremarkable. CT revealed an enhancing lesion located in the right parietal lobe, with mild mass effect on the right occipital horn, indicative of a brain abscess. The patient was initially treated with a course of empirical antibiotics, including ceftriaxone, vancomycin, metronidazole and dexamethasone. The neurosurgery team aspirated the abscess the following day and extracted yellow pus that was sampled for bacterial and fungal cultures. These cultures returned positive for Rhinocladiella mackenziei, prompting a discontinuation of the empirical antibiotics and initiation of intravenous liposomal amphotericin B for 4 weeks. Intravenous posaconazole was added to the patient's existing therapy regimen, which was substituted with oral isavuconazole on discharge. The patient continues to take isavuconazole, and follow-up imaging has demonstrated regression of the abscess.

Keywords: Infection (neurology); Infectious diseases.

Publication types

  • Case Reports

MeSH terms

  • Anti-Bacterial Agents
  • Brain Abscess*
  • Cerebral Phaeohyphomycosis*
  • Headache
  • Humans
  • Male

Substances

  • isavuconazole
  • Anti-Bacterial Agents

Supplementary concepts

  • Rhinocladiella mackenziei